A2A adenosine receptor signaling in lymphocytes and the central nervous system regulates inflammation during experimental autoimmune encephalomyelitis

Journal of Immunology

Volumn 188, Issue 11, 2012, Pages 5713-5722

  Mills, Jeffrey H ^a   Kim, Do Geun ^a   Krenz, Antje ^a   Chen, Jiang Fan ^b   Bynoe, Margaret S ^a  

^a Department of Obstetrics Gynecology   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR ANTAGONIST; GAMMA INTERFERON;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CENTRAL NERVOUS SYSTEM; CHOROID PLEXUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEMATOPOIETIC CELL; IMMUNOREGULATION; INFLAMMATION; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INFLAMMATION MEDIATORS; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTOR, ADENOSINE A2A; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; SPINAL CORD; UP-REGULATION;

EID: 84862073627     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200545     Document Type: Article

References (81)

1. Fredholm, B. B., A. P. IJzerman, K. A. Jacobson, J. Linden, and C. E. Müller. 2011. International Union of Basic and Clinical Pharmacology, LXXXI. Nomenclature and classification of adenosine receptors - an update. Pharmacol. Rev. 63: 1-34.
2. Blackburn, M. R., C. O. Vance, E. Morschl, and C. N. Wilson. 2009. Adenosine receptors and inflammation. Handb. Exp. Pharmacol. 2009: 215-269.
3. Cook, S. P., and E. W. McCleskey. 2002. Cell damage excites nociceptors through release of cytosolic ATP. Pain 95: 41-47. (Pubitemid 34076776)
4. Motte, S., D. Communi, S. Pirotton, and J. M. Boeynaems. 1995. Involvement of multiple receptors in the actions of extracellular ATP: the example of vascular endothelial cells. Int. J. Biochem. Cell Biol. 27: 1-7.
5. Deaglio, S., K. M. Dwyer, W. Gao, D. Friedman, A. Usheva, A. Erat, J. F. Chen, K. Enjyoji, J. Linden, M. Oukka, et al. 2007. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204: 1257-1265. (Pubitemid 46919862)
6. Mistry, G., and G. I. Drummond. 1986. Adenosine metabolism in microvessels from heart and brain. J. Mol. Cell. Cardiol. 18: 13-22. (Pubitemid 16174711)
7. Redzic, Z. B., J. Biringer, K. Barnes, S. A. Baldwin, H. Al-Sarraf, P. A. Nicola, J. D. Young, C. E. Cass, M. A. Barrand, and S. B. Hladky. 2005. Polarized distribution of nucleoside transporters in rat brain endothelial and choroid plexus epithelial cells. J. Neurochem. 94: 1420-1426. (Pubitemid 41232597)
8. Odashima, M., G. Bamias, J. Rivera-Nieves, J. Linden, C. C. Nast, C. A. Moskaluk, M. Marini, K. Sugawara, K. Kozaiwa, M. Otaka, et al. 2005. Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease. Gastroenterology 129: 26-33. (Pubitemid 41002039)
9. Boppana, S., H. Huang, K. Ito, and S. Dhib-Jalbut. 2011. Immunologic aspects of multiple sclerosis. Mt. Sinai J. Med. 78: 207-220.
10. Ben-Zacharia, A. B. 2011. Therapeutics for multiple sclerosis symptoms. Mt. Sinai J. Med. 78: 176-191.
11. Buck, D., and B. Hemmer. 2011. Treatment of multiple sclerosis: current concepts and future perspectives. J. Neurol. 258: 1747-1762.
12. Lappas, C. M., J. M. Rieger, and J. Linden. 2005. A2A adenosine receptor induction inhibits IFN-γ production in murine CD4+ T cells. J. Immunol. 174: 1073-1080. (Pubitemid 40094304)
13. Yang, Z., Y. J. Day, M. C. Toufektsian, Y. Xu, S. I. Ramos, M. A. Marshall, B. A. French, and J. Linden. 2006. Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes. Circulation 114: 2056-2064. (Pubitemid 44706882)
14. Raskovalova, T., A. Lokshin, X. Huang, E. K. Jackson, and E. Gorelik. 2006. Adenosine-mediated inhibition of cytotoxic activity and cytokine production by IL-2/NKp46-activated NK cells: involvement of protein kinase A isozyme I (PKA I). Immunol. Res. 36: 91-99. (Pubitemid 46398612)
15. Eltzschig, H. K., L. F. Thompson, J. Karhausen, R. J. Cotta, J. C. Ibla, S. C. Robson, and S. P. Colgan. 2004. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood 104: 3986-3992. (Pubitemid 39620148)
16. Harada, N., K. Okajima, K. Murakami, S. Usune, C. Sato, K. Ohshima, and T. Katsuragi. 2000. Adenosine and selective A(2A) receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation. J. Pharmacol. Exp. Ther. 294: 1034-1042. (Pubitemid 30666856)
17. Wakai, A., J. H. Wang, D. C. Winter, J. T. Street, R. G. O'Sullivan, and H. P. Redmond. 2001. Adenosine inhibits neutrophil vascular endothelial growth factor release and transendothelial migration via A2B receptor activation. Shock 15: 297-301. (Pubitemid 33596722)
18. Salmon, J. E., N. Brogle, C. Brownlie, J. C. Edberg, R. P. Kimberly, B. X. Chen, and B. F. Erlanger. 1993. Human mononuclear phagocytes express adenosine A1 receptors: a novel mechanism for differential regulation of Fcγ receptor function. J. Immunol. 151: 2775-2785. (Pubitemid 23264529)
19. Eppell, B. A., A. M. Newell, and E. J. Brown. 1989. Adenosine receptors are expressed during differentiation of monocytes to macrophages in vitro: implications for regulation of phagocytosis. J. Immunol. 143: 4141-4145. (Pubitemid 20012606)
20. Zhang, J. G., L. Hepburn, G. Cruz, R. A. Borman, and K. L. Clark. 2005. The role of adenosine A2A and A2B receptors in the regulation of TNF-α production by human monocytes. Biochem. Pharmacol. 69: 883-889. (Pubitemid 40312706)
21. Chen, L., B. B. Fredholm, and M. Jondal. 2008. Adenosine, through the A1 receptor, inhibits vesicular MHC class I cross-presentation by resting DC. Mol. Immunol. 45: 2247-2254.
22. Panther, E., S. Corinti, M. Idzko, Y. Herouy, M. Napp, A. la Sala, G. Girolomoni, and J. Norgauer. 2003. Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells. Blood 101: 3985-3990. (Pubitemid 36857876)
23. Louis, N. A., A. M. Robinson, C. F. MacManus, J. Karhausen, M. Scully, and S. P. Colgan. 2008. Control of IFN-αA by CD73: implications for mucosal inflammation. J. Immunol. 180: 4246-4255.
24. Mills, J. H., L. F. Thompson, C. Mueller, A. T. Waickman, S. Jalkanen, J. Niemela, L. Airas, and M. S. Bynoe. 2008. CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 105: 9325-9330.
25. Day, Y. J., M. A. Marshall, L. Huang, M. J. McDuffie, M. D. Okusa, and J. Linden. 2004. Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G285-G293. (Pubitemid 38134040)
26. Lau, C. L., Y. Zhao, I. L. Kron, M. H. Stoler, V. E. Laubach, G. Ailawadi, and J. Linden. 2009. The role of adenosine A2A receptor signaling in bronchiolitis obliterans. Ann. Thorac. Surg. 88: 1071-1078.
27. + helper T cells and regulates Helicobacter- induced gastritis and bacterial persistence. Mucosal Immunol. 2: 232-242.
28. Cronstein, B. N., L. Daguma, D. Nichols, A. J. Hutchison, and M. Williams. 1990. The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively. J. Clin. Invest. 85: 1150-1157. (Pubitemid 20123757)
29. Rose, F. R., R. Hirschhorn, G.Weissmann, and B. N. Cronstein. 1988. Adenosine promotes neutrophil chemotaxis. J. Exp. Med. 167: 1186-1194.
30. Panther, E., M. Idzko, Y. Herouy, H. Rheinen, P. J. Gebicke-Haerter, U. Mrowietz, S. Dichmann, and J. Norgauer. 2001. Expression and function of adenosine receptors in human dendritic cells. FASEB J. 15: 1963-1970. (Pubitemid 32848800)
31. Allen-Gipson, D. S., K. Spurzem, N. Kolm, J. R. Spurzem, and T. A. Wyatt. 2007. Adenosine promotion of cellular migration in bronchial epithelial cells is mediated by the activation of cyclic adenosine monophosphate-dependent protein kinase A. J. Investig. Med. 55: 378-385. (Pubitemid 351211318)
32. Tsutsui, S., J. Schnermann, F. Noorbakhsh, S. Henry, V. W. Yong, B. W. Winston, K. Warren, and C. Power. 2004. A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. J. Neurosci. 24: 1521-1529. (Pubitemid 38223004)
33. Chen, G. Q., Y. Y. Chen, X. S. Wang, S. Z. Wu, H. M. Yang, H. Q. Xu, J. C. He, X. T. Wang, J. F. Chen, and R. Y. Zheng. 2010. Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats. Brain Res. 1309: 116-125.
34. Brown, D. A., and P. E. Sawchenko. 2007. Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis. J. Comp. Neurol. 502: 236-260. (Pubitemid 46595397)
35. Engelhardt, B., K. Wolburg-Buchholz, and H. Wolburg. 2001. Involvement of the choroid plexus in central nervous system inflammation. Microsc. Res. Tech. 52: 112-129. (Pubitemid 32065034)
36. Steffen, B. J., G. Breier, E. C. Butcher, M. Schulz, and B. Engelhardt. 1996. ICAM-1, VCAM-1, and MAdCAM-1 are expressed on choroid plexus epithelium but not endothelium and mediate binding of lymphocytes in vitro. Am. J. Pathol. 148: 1819-1838.
37. Chen, J. F., Z. Huang, J. Ma, J. Zhu, R. Moratalla, D. Standaert, M. A. Moskowitz, J. S. Fink, and M. A. Schwarzschild. 1999. A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci. 19: 9192-9200. (Pubitemid 30228071)
38. Bettelli, E., M. Pagany, H. L. Weiner, C. Linington, R. A. Sobel, and V. K. Kuchroo. 2003. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197: 1073-1081. (Pubitemid 36570063)
39. Bynoe, M. S., J. T. Evans, C. Viret, and C. A. Janeway, Jr. 2003. Epicutaneous immunization with autoantigenic peptides induces T suppressor cells that prevent experimental allergic encephalomyelitis. Immunity 19: 317-328. (Pubitemid 37153409)
40. Carman, A. J., J. H. Mills, A. Krenz, D. G. Kim, and M. S. Bynoe. 2011. Adenosine receptor signaling modulates permeability of the blood-brain barrier. J. Neurosci. 31: 13272-13280.
41. Spangrude, G. J. 2008. Assessment of lymphocyte development in radiation bone marrow chimeras. Curr. Protoc. Immunol. Chapter 4: Unit 4.6.
42. Spangrude, G. J., D. M. Brooks, and D. B. Tumas. 1995. Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: in vivo expansion of stem cell phenotype but not function. Blood 85: 1006-1016.
43. Staples, J. E., N. C. Fiore, D. E. Frazier, Jr., T. A. Gasiewicz, and A. E. Silverstone. 1998. Overexpression of the anti-apoptotic oncogene, bcl-2, in the thymus does not prevent thymic atrophy induced by estradiol or 2,3,7, 8- tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 151: 200-210. (Pubitemid 28406668)
44. Fletcher, J. M., S. J. Lalor, C. M. Sweeney, N. Tubridy, and K. H. Mills. 2010. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin. Exp. Immunol. 162: 1-11.
45. Bhasin, M., M. Wu, and S. E. Tsirka. 2007. Modulation of microglial/ macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis. BMC Immunol. 8: 10.
46. Lassmann, H., M. Schmied, K. Vass, and W. F. Hickey. 1993. Bone marrow derived elements and resident microglia in brain inflammation. Glia 7: 19-24.
47. Ito, D., Y. Imai, K. Ohsawa, K. Nakajima, Y. Fukuuchi, and S. Kohsaka. 1998. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res. Mol. Brain Res. 57: 1-9. (Pubitemid 28279554)
48. Kettenmann, H., U. K. Hanisch, M. Noda, and A. Verkhratsky. 2011. Physiology of microglia. Physiol. Rev. 91: 461-553.
49. El-behi, M., A. Rostami, and B. Ciric. 2010. Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. J. Neuroimmune Pharmacol. 5: 189-197.
50. Huang, S., S. Apasov, M. Koshiba, and M. Sitkovsky. 1997. Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 90: 1600-1610. (Pubitemid 27355433)
51. Josefowicz, S. Z., L. F. Lu, and A. Y. Rudensky. 2012. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30: 531-564.
52. Kumar, V., K. Stellrecht, and E. Sercarz. 1996. Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE). J. Exp. Med. 184: 1609-1617. (Pubitemid 26404454)
53. Zarek, P. E., C. T. Huang, E. R. Lutz, J. Kowalski, M. R. Horton, J. Linden, C. G. Drake, and J. D. Powell. 2008. A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood 111: 251-259.
54. Moreau, J. L., and G. Huber. 1999. Central adenosine A(2A) receptors: an overview. Brain Res. Brain Res. Rev. 31: 65-82. (Pubitemid 30009614)
55. Dixon, A. K., A. K. Gubitz, D. J. Sirinathsinghji, P. J. Richardson, and T. C. Freeman. 1996. Tissue distribution of adenosine receptor mRNAs in the rat. Br. J. Pharmacol. 118: 1461-1468. (Pubitemid 26248800)
56. + T cells are resistant to the induction of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 70: 139-144.
57. Reutershan, J., R. E. Cagnina, D. Chang, J. Linden, and K. Ley. 2007. Therapeutic anti-inflammatory effects of myeloid cell adenosine receptor A2a stimulation in lipopolysaccharide-induced lung injury. J. Immunol. 179: 1254-1263.
58. Li, Y., R. J. Oskouian, Y. J. Day, J. M. Rieger, L. Liu, J. A. Kern, and J. Linden. 2006. Mouse spinal cord compression injury is reduced by either activation of the adenosine A2A receptor on bone marrow-derived cells or deletion of the A2A receptor on non-bone marrow-derived cells. Neuroscience 141: 2029-2039. (Pubitemid 44233122)
59. Dai, S. S., and Y. G. Zhou. 2011. Adenosine 2A receptor: a crucial neuromodulator with bidirectional effect in neuroinflammation and brain injury. Rev. Neurosci. 22: 231-239.
60. Rivo, J., E. Zeira, E. Galun, S. Einav, J. Linden, and I. Matot. 2007. Attenuation of reperfusion lung injury and apoptosis by A2A adenosine receptor activation is associated with modulation of Bcl-2 and Bax expression and activation of extracellular signal-regulated kinases. Shock 27: 266-273.
61. Haskó, G., D. G. Kuhel, J. F. Chen, M. A. Schwarzschild, E. A. Deitch, J. G. Mabley, A. Marton, and C. Szabó . 2000. Adenosine inhibits IL-12 and TNF-α production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J. 14: 2065-2074.
62. Kreckler, L. M., E. Gizewski, T. C. Wan, and J. A. Auchampach. 2009. Adenosine suppresses lipopolysaccharide-induced tumor necrosis factor-α production by murine macrophages through a protein kinase A- and exchange protein activated by cAMP-independent signaling pathway. J. Pharmacol. Exp. Ther. 331: 1051-1061.
63. Meininger, C. J., M. E. Schelling, and H. J. Granger. 1988. Adenosine and hypoxia stimulate proliferation and migration of endothelial cells. Am. J. Physiol. 255: H554-H562.
64. Lutty, G. A., M. K. Mathews, C. Merges, and D. S. McLeod. 1998. Adenosine stimulates canine retinal microvascular endothelial cell migration and tube formation. Curr. Eye Res. 17: 594-607. (Pubitemid 28288658)
65. Othman, T., H. Yan, and S. A. Rivkees. 2003. Oligodendrocytes express functional A1 adenosine receptors that stimulate cellular migration. Glia 44: 166-172. (Pubitemid 37345626)
66. Knight, D., X. Zheng, C. Rocchini, M. Jacobson, T. Bai, and B. Walker. 1997. Adenosine A3 receptor stimulation inhibits migration of human eosinophils. J. Leukoc. Biol. 62: 465-468. (Pubitemid 27459775)
67. + channel KCa3.1 in human lung mast cells and inhibits their migration via the adenosine A2A receptor. Eur. J. Immunol. 37: 1653-1662.
68. Choi, I. Y., J. C. Lee, C. Ju, S. Hwang, G. S. Cho, H. W. Lee, W. J. Choi, L. S. Jeong, and W. K. Kim. 2011. A3 adenosine receptor agonist reduces brain ischemic injury and inhibits inflammatory cell migration in rats. Am. J. Pathol. 179: 2042-2052.
69. Säve, S., C. Mohlin, R. Vumma, and K. Persson. 2011. Activation of adenosine A2A receptors inhibits neutrophil transuroepithelial migration. Infect. Immun. 79: 3431-3437.
70. Bours, M. J., E. L. Swennen, F. Di Virgilio, B. N. Cronstein, and P. C. Dagnelie. 2006. Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol. Ther. 112: 358-404. (Pubitemid 44486409)
71. Grenz, A., D. Homann, and H. K. Eltzschig. 2011. Extracellular adenosine: a safety signal that dampens hypoxia-induced inflammation during ischemia. Antioxid. Redox Signal. 15: 2221-2234.
72. Trautmann, A. 2009. Extracellular ATP in the immune system: more than just a "danger signal". Sci. Signal. 2: pe6.
73. Carson, M. J., J. M. Doose, B. Melchior, C. D. Schmid, and C. C. Ploix. 2006. CNS immune privilege: hiding in plain sight. Immunol. Rev. 213: 48-65. (Pubitemid 44401493)
74. Eltzschig, H. K., and P. Carmeliet. 2011. Hypoxia and inflammation. N. Engl. J. Med. 364: 656-665.
75. Morote-Garcia, J. C., P. Rosenberger, N. M. Nivillac, I. R. Coe, and H. K. Eltzschig. 2009. Hypoxia-inducible factor-dependent repression of equilibrative nucleoside transporter 2 attenuates mucosal inflammation during intestinal hypoxia. Gastroenterology 136: 607-618.
76. Morote-Garcia, J. C., P. Rosenberger, J. Kuhlicke, and H. K. Eltzschig. 2008. HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak. Blood 111: 5571-5580.
77. Rosenberger, P., J. M. Schwab, V. Mirakaj, E. Masekowsky, A. Mager, J. C. Morote-Garcia, K. Unertl, and H. K. Eltzschig. 2009. Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat. Immunol. 10: 195-202.
78. Moon, C., M. Ahn, C. Jeong, H. Kim, and T. Shin. 2011. Immunohistochemical study of netrin-1 in the spinal cord with rat experimental autoimmune encephalomyelitis. Immunol. Invest. 40: 160-171.
79. Moreno, B., B. Fernandez-Diez, A. Di Penta, and P. Villoslada. 2010. Preclinical studies of methylthioadenosine for the treatment of multiple sclerosis. Mult. Scler. 16: 1102-1108.
80. Moreno, B., H. Hevia, M. Santamaria, J. Sepulcre, J. Muñoz, E. R. García- Trevijano, C. Berasain, F. J. Corrales, M. A. Avila, and P. Villoslada. 2006.Methylthioadenosine reverses brain autoimmune disease. Ann. Neurol. 60: 323-334. (Pubitemid 44520235)
81. Munshi, R., A. S. Clanachan, and H. P. Baer. 1988. 5′-Deoxy- 5′-methylthioadenosine: a nucleoside which differentiates between adenosine receptor types. Biochem. Pharmacol. 37: 2085-2089.